Opus Genetics, Inc.

Opus Genetics, Inc. - ROEverified

IRD

Price:

$4.07

Market Cap:

$336.04M

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 pro...[Read more]

Industry

Biotechnology

IPO Date

2015-01-19

Stock Exchange

NASDAQ

Ticker

IRD

The ROE as of June 2026 (TTM) for Opus Genetics, Inc. (IRD) is 6.07%

According to Opus Genetics, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.07%. This represents a change of -8201.09% compared to the average of -74.91% of the last 4 quarters.

Opus Genetics, Inc. (IRD) Historical ROE (quarterly & annually)

How has IRD ROE performed in the past?

The mean historical ROE of Opus Genetics, Inc. over the last ten years is -164.39%. The current 6.07% ROE has changed -3791.61% with respect to the historical average. Over the past ten years (40 quarters), IRD's ROE was at its highest in in the March 2026 quarter at 142.98%. The ROE was at its lowest in in the December 2024 quarter at -522.53%.

Quarterly (TTM)
Annual

Average

-164.39%

Median

-20.01%

Minimum

-855.62%

Maximum

182.82%

Opus Genetics, Inc. (IRD) ROE by Quarter and Year

Discovering the peaks and valleys of Opus Genetics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.18%

Maximum Annual ROE = 182.82%

Minimum Annual Increase = -239.55%

Minimum Annual ROE = -855.62%

Quarterly (TTM)
Annual
YearROEChange
2025-323.11%-62.24%
2024-855.62%4.18%
2023-20.01%-151.72%
202238.69%-115.16%
2021-255.12%-239.55%
2020182.82%124.04%

Opus Genetics, Inc. (IRD) Average ROE

How has IRD ROE performed in the past?

The current ROE of Opus Genetics, Inc. (IRD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-399.58%

5-year avg

-283.04%

10-year avg

-164.39%

Opus Genetics, Inc. (IRD) ROE vs. Peers

How is IRD’s ROE compared to its peers?

Opus Genetics, Inc.’s ROE is greater than Acumen Pharmaceuticals, Inc. (-123.07%), greater than Seer, Inc. (-26.58%), greater than Agenus Inc. (-23.05%), greater than Inovio Pharmaceuticals, Inc. (-666.47%), greater than VistaGen Therapeutics, Inc. (-133.02%), greater than TuHURA Biosciences, Inc. (-153.99%), greater than Alector, Inc. (-295.17%), greater than Cognition Therapeutics, Inc. (-72.68%), greater than Instil Bio, Inc. (-39.76%), greater than Seres Therapeutics, Inc. (-127.30%),

Build a custom stock screener for Opus Genetics, Inc. (IRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opus Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opus Genetics, Inc. (IRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opus Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Opus Genetics, Inc.'s ROE?

How is the ROE calculated for Opus Genetics, Inc. (IRD)?

What is the highest ROE for Opus Genetics, Inc. (IRD)?

What is the 3-year average ROE for Opus Genetics, Inc. (IRD)?

What is the 5-year average ROE for Opus Genetics, Inc. (IRD)?

How does the current ROE for Opus Genetics, Inc. (IRD) compare to its historical average?